Myron S. COHEN, University of North Carolina, Chapel Hill, USA
“There is compelling evidence that antiretroviral treatment has the potential to stop the spread of HIV. The critical and urgent importance of earlier and wider antiretroviral treatment for people with HIV infection will be described along with the substantial challenges to the use of treatment as prevention, and what we can immediately do to overcome these challenges.”
Myron S. Cohen is the J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Epidemiology at the University of North Carolina at Chapel Hill. Dr. Cohen completed Internal Medicine Training at the University of Michigan, and an Infectious Disease Fellowship at Yale University. Dr. Cohen is member of the Institute of Medicine, a Fellow of the American College of Physicians and the Infectious Disease Society of America, and a member of the American Society of Clinical Investigation and the American Association of Physicians.
Dr. Cohen serves as the Director of the UNC Division of Infectious Disease and the UNC Institute for Global Health and Infectious Disease, and as Associate Vice Chancellor. Dr. Cohen serves as Co-PI of the NIH HIV Prevention Trials Network.
Dr. Cohen received the Distinguished Alumnus Award from Rush Medical College in 2000, the Thomas Parran Award in 2005 from the American Sexually Transmitted Diseases Association and the O. Max Gardner Award in 2008, the highest honor of the University of North Carolina.
Dr. Cohen has received 30 years of continuous funding from the NIH, including a MERIT Award, for his HIV research. Dr. Cohen is the architect and Principal Investigator of the multinational trial HPTN 052, recognized by Science Magazine as the “Breakthrough of the Year” in 2011 for demonstration of the power of antiretroviral agents to prevent HIV transmission. He is the author of more than 500 publications.
« Go Back